BRPI0409640A - método de prevenção de doenças de reprodução de gado - Google Patents

método de prevenção de doenças de reprodução de gado

Info

Publication number
BRPI0409640A
BRPI0409640A BRPI0409640-1A BRPI0409640A BRPI0409640A BR PI0409640 A BRPI0409640 A BR PI0409640A BR PI0409640 A BRPI0409640 A BR PI0409640A BR PI0409640 A BRPI0409640 A BR PI0409640A
Authority
BR
Brazil
Prior art keywords
leptospira
virus
type
bovine
vaccine
Prior art date
Application number
BRPI0409640-1A
Other languages
English (en)
Inventor
Michael Aaron Ellsworth
Martin Dale Ficken
Brian James Fergen
Cassius Mcallister Tucker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0409640A publication Critical patent/BRPI0409640A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"MéTODO DE PREVENçãO DE DOENçAS DE REPRODUçãO DE GADO". A presente invenção refere-se a métodos para prevenir ou tratar doenças ou distúrbios em vacas prenhes e bezerros lactentes de vacas prenhes causados por infecção por Vírus de Diarréia Vírica Bovina (BVDV) Tipo 1 e 2, Vírus de Herpes Bovino Tipo-1 (BHV-1), Vírus Respiratório Sincicial Bovino (BRSV), Vírus de Parainfluenza Tipo 3 (PIV~ 3~), Campylobacter fetus, Leptospira canicola, Leptospira grippotyphosa, Leptospira borgpetersenili hardjo-prjitno, Leptospira icterohaemmorrhagiae, Leptospira borgpetersenii hardjo-bovis e Leptospira interrogans pomona, por administração ao animal de uma quantidade eficaz de uma de vacina de combinação segura de vírus vivos modificados adicionalmente combinada com uma vacina bacterina multivalente.
BRPI0409640-1A 2003-04-21 2004-04-13 método de prevenção de doenças de reprodução de gado BRPI0409640A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/419,661 US7563449B2 (en) 2003-04-21 2003-04-21 Methods for reducing cattle reproductive diseases
PCT/IB2004/001292 WO2004093904A2 (en) 2003-04-21 2004-04-13 Modified live vaccines comprising bhv-1(ibr) and/or bvdv pregnant and nursing cattles

Publications (1)

Publication Number Publication Date
BRPI0409640A true BRPI0409640A (pt) 2006-04-25

Family

ID=33159354

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409640-1A BRPI0409640A (pt) 2003-04-21 2004-04-13 método de prevenção de doenças de reprodução de gado

Country Status (16)

Country Link
US (3) US7563449B2 (pt)
EP (1) EP1617866A2 (pt)
JP (1) JP2006524224A (pt)
KR (1) KR20060013509A (pt)
CN (1) CN1777442A (pt)
AR (1) AR043892A1 (pt)
AU (1) AU2004231359B2 (pt)
BR (1) BRPI0409640A (pt)
CA (1) CA2426280C (pt)
CL (1) CL2004000799A1 (pt)
CO (1) CO5611162A2 (pt)
MX (1) MXPA05011278A (pt)
RU (1) RU2005128790A (pt)
TW (1) TW200505477A (pt)
UY (1) UY28274A1 (pt)
WO (1) WO2004093904A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7563449B2 (en) * 2003-04-21 2009-07-21 Pfizer Inc, Methods for reducing cattle reproductive diseases
US7361357B2 (en) 2003-07-29 2008-04-22 Pfizer Inc. Safe mutant viral vaccines
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
EP2371382B1 (en) 2005-12-29 2016-03-02 Boehringer Ingelheim Vetmedica, Inc. Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
EP2275132B1 (en) 2005-12-29 2021-03-03 Boehringer Ingelheim Animal Health USA Inc. Multivalent PCV2 immunogenic compositions and methods of producing them
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
KR101619730B1 (ko) 2006-12-15 2016-05-12 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 항원을 이용한 돼지의 치료
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
AU2010264686A1 (en) 2009-06-24 2012-01-19 Glaxosmithkline Biologicals S.A. Vaccine
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
PL2658570T3 (pl) * 2010-12-27 2019-05-31 Elanco Inc Sposoby i kompozycje szczepionki przeciwko wirusowi wirusowej biegunki bydła typu 1b
WO2012170753A2 (en) * 2011-06-10 2012-12-13 Novartis Ag Bovine vaccines and methods
MX2016004063A (es) 2013-10-02 2016-06-06 Boehringer Ingelheim Vetmed Variante de la proteina pcv2 orf2 y particulas similares al virus compuestas por esta.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030054505A1 (en) * 1997-09-26 2003-03-20 Hong Jin Recombinant rsv expression systems and vaccines
KR20050062542A (ko) * 2002-08-26 2005-06-23 화이자 프로덕츠 인코포레이티드 소의 호흡기 및 생식기계 감염에 대한 백신
US7563449B2 (en) * 2003-04-21 2009-07-21 Pfizer Inc, Methods for reducing cattle reproductive diseases

Also Published As

Publication number Publication date
US20040208901A1 (en) 2004-10-21
WO2004093904A2 (en) 2004-11-04
AR043892A1 (es) 2005-08-17
MXPA05011278A (es) 2006-01-24
UY28274A1 (es) 2004-11-30
CN1777442A (zh) 2006-05-24
US20070154943A1 (en) 2007-07-05
CO5611162A2 (es) 2006-02-28
RU2005128790A (ru) 2006-06-10
AU2004231359B2 (en) 2009-07-23
CA2426280C (en) 2014-11-18
US20070172877A1 (en) 2007-07-26
JP2006524224A (ja) 2006-10-26
CL2004000799A1 (es) 2005-04-22
TW200505477A (en) 2005-02-16
AU2004231359A1 (en) 2004-11-04
WO2004093904A3 (en) 2004-12-23
KR20060013509A (ko) 2006-02-10
CA2426280A1 (en) 2004-10-21
EP1617866A2 (en) 2006-01-25
US7563449B2 (en) 2009-07-21

Similar Documents

Publication Publication Date Title
BRPI0409640A (pt) método de prevenção de doenças de reprodução de gado
UA94689C2 (ru) Вакцина против инфекций дыхательной и репродуктивной систем у скота
Lorenz et al. Calf health from birth to weaning. III. Housing and management of calf pneumonia
BG108496A (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
RU2006133328A (ru) Способ вакцинации против инфекции семенников bvdv
AR019579A1 (es) USO DE UN INICIADOR DE LA RESPUESTA SEXUAL DEL SISTEMA NERVIOSO CENTRAL PARA LA FABRICACIoN DE UNA COMPOSICIoN FARMACÉUTICA PARA LA NORMALIZACIoN DE LA CRONOMETRACIoN DE LA RESPUESTA SEXUAL O PARA LA PROFILAXIS O REDUCCIoN DE LA LESIoN TISULAR GENITAL EN MAMíFEROS
Laurent Alternatives to Common Preventive Uses of Antibiotics for Cattle, Swine, and Chickens
De Jong Prevention of Atrophic Rhinitis in piglets by means of intranasal administration of a live non‐AR‐pathogenic Bordetella bronchiseptica vaccine
TH72040A (th) วิธีสำหรับการป้องกันโรคระบบสืบพันธุ์ของวัวควาย
Stoltenow et al. Immunologic responses of beef calves to concurrent application of modified-live viral vaccine (intranasal and systemic administration) and systemically administered Mannheimia haemolytica bacterin-leukotoxoid.
Bojkovski et al. Breeding disease and welfare calves on dairy farms tied breeding system
DOP2003000699A (es) Vacunas para enfermedades reproductoras del ganado
Dikmen et al. PSXI-37 Differences in thermoregulation ability and genetic parameters of skin traits in Angus, Brahman and their crossbreds
Ryan et al. Leptospirosis in dairy farmers: prevention by vaccination of cattle
Wittmann Aujeszky’s disease (Pseudorabies) in ruminants
Sharon Effects of on-arrival, delayed vaccination and supplemental lysine on performance, antibody titer, temperature and metabolic profiles in response to modified-live viral respiratory vaccination
Iveson et al. Health and welfare of pigs before and after weaning
Rugg et al. Efficacy of ivermectin jetting fluid against strike by some primary and secondary blowflies of sheep
Smith Respiratory disease in dairy calves.
RU2203632C2 (ru) Способ профилактики и лечения заболеваний крупных животных
Pullen et al. Canine distemper
Kushwaha et al. Centbucridine hydrochloride for epidural analgesia in cattle: Haematological studies
Campbell Effectiveness of vaccination programs in replacement heifers
Spire Bovine immunizations

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired